Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Adrian Hugh Brasnett has worked on the following 166 EPO patent applications which have been published in the last five years:

EP11751387

TRANSCRIPTION REGULATORS FOR IMPROVING PLANT PERFORMANCE

IPC classification:
A01H 1/00, C07H 21/00, C12N 15/29
Agent:
Zacco Denmark A/S
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The patent has been granted
EP11724846

SQUALANE AND ISOSQUALANE COMPOSITIONS AND METHODS FOR PREPARING THE SAME

IPC classification:
C07C 2/04, C07C 9/22, C07C 11/21, C10M 127/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11829786

IN VIVO REPORTER SYSTEM

IPC classification:
C07H 21/00, C12Q 1/68
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12180037

Microfluidic detection of analytes

IPC classification:
B01L 3/00, G01N 1/40, G01N 27/26, G01N 33/536
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11785541

VACCINES COMPRISING NON-SPECIFIC NUCLEOSIDE HYDROLASE AND STEROL 24-C-METHYLTRANSFERASE (SMT) POLYPEPTIDES FOR THE TREATMENT AND DIAGNOSIS OF LEISHMANIASIS

IPC classification:
A61K 39/008, C07K 14/44, C12N 15/62
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11790705

TREATMENT OF CANCER WITH ELEVATED DOSAGES OF SOLUBLE FGFR1 FUSION PROTEINS

IPC classification:
A61K 38/17, A61P 35/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11784918

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

IPC classification:
A61K 31/337, A61K 31/4745, A61K 31/475, A61K 31/513, A61K 31/519, A61K 31/555, A61K 31/704, A61K 31/7048, A61K 33/24, A61K 38/17, A61K 38/18, A61K 39/395, A61K 45/06, A61P 35/00, C07K 19/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11787193

NOVEL REPORTER CONSTRUCTS FOR COMPOUND SCREENING

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Andrew John Thompson, Withers & Rogers LLP
Status:
EXAMINATION IN PROGRESS
EP12737028

SOMATIC CELLS WITH INNATE POTENTIAL FOR PLURIPOTENCY

IPC classification:
C12N 5/071
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11715321

VACCINES FOR PANDEMIC INFLUENZA

IPC classification:
A61K 39/145, A61K 39/39
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11831627

TISSUE-INTEGRATING SENSORS

IPC classification:
A61B 5/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12713848

IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR INDUCING HUMORAL AND CELLULAR IMMUNE RESPONSES

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12706967

BASE OILS AND METHODS FOR MAKING THE SAME

IPC classification:
C07C 2/58, C07C 5/03, C10M 177/00
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12708189

OLEFINS AND METHODS FOR MAKING THE SAME

IPC classification:
C07C 5/05
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12720058

METHODS FOR GENOMIC MODIFICATION

IPC classification:
C12N 15/81, C12N 15/90
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12723327

METHODS AND COMPOSITIONS FOR DETECTING MICROBIAL PRODUCTION OF WATER-IMMISCIBLE COMPOUNDS

IPC classification:
C12P 5/00, G01N 33/58
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11841347

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII

IPC classification:
A61K 38/00, A61K 38/18, A61K 39/00, C07K 14/71, C12N 15/00, C12P 21/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11772484

METHODS OF TREATING GLUCOSE METABOLISM DISORDERS

IPC classification:
A61K 38/00, A61K 38/28, A61P 3/08, A61P 3/10, A61P 7/12
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11835168

BODY FLUID BIN1 AS A MARKER OF CARDIAC HEALTH

IPC classification:
C07K 14/435, G01N 33/50, G01N 33/68
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11829785

MODEL FOR MUSCLE ATROPHY

IPC classification:
A01K 67/00, A01K 67/027, C12N 15/00, C12N 15/85, G01N 33/50
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11760223

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS

IPC classification:
A61K 31/7088, A61K 39/395, A61P 25/00, C07K 16/40, C12N 15/113
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12797060

MACROMOLECULES

IPC classification:
A61K 31/00, A61K 38/00, A61K 39/00, A61K 47/34, A61K 47/48, C08G 73/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12743036

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE

IPC classification:
A61K 9/00, A61K 38/48, A61P 1/00, A61P 37/00, A61P 39/00, G01N 33/53
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13172042

Vaccine composition containing synthetic adjuvant

IPC classification:
A61K 31/7028, A61K 39/008, A61K 39/04, A61K 39/145, A61P 37/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12714910

METHODS AND COMPOSITIONS FOR NORMALIZATION OF TUMOR VASCULATURE BY INHIBITION OF LOXL2

IPC classification:
A61K 31/7088, C07K 16/40
Applicant:
Gilead Biologics, Inc.
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826796

ENGINEERED SEQUENCES TO FACILITATE EXPRESSION OF ANTIGENS IN NEISSERIA AND METHODS OF USE

IPC classification:
A61K 39/095
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12827654

METHODS FOR GENERATING CARDIOMYOCYTES

IPC classification:
A01N 63/00, A01N 65/00, C12N 5/00, C12N 5/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12831844

DETECTION OF VIRAL INFECTION

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13172134

GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis

IPC classification:
A61K 38/00, A61K 39/00, A61K 39/02, A61K 39/095, A61K 39/116, C07K 1/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12838704

METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION

IPC classification:
A61K 31/7088, C12N 15/55
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14164800

Nucleic acids, compositions and methods for the excision of target nucleic acids

IPC classification:
C12N 15/81
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14158177

Method and composition for crystallizing G protein-coupled receptors

IPC classification:
C12P 21/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11725852

METHODS OF TREATING HEMATOLOGICAL DISORDERS WITH QUINAZOLINONE COMPOUNDS IN SELECTED PATIENTS

IPC classification:
A61K 31/517, A61K 31/52, A61P 35/02
Applicant:
Gilead Calistoga LLC
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13194273

Non-integrating lentiviral vectors

IPC classification:
A61K 39/00, C12N 15/867
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12845201

REPROGRAMMING OF CELLULAR ADHESION

IPC classification:
A61K 9/127
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13154049

Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use

IPC classification:
A61K 39/095, C07K 16/12
Applicant:
Novartis Vaccines and Diagnostics Srl
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12795948

PRODUCTION OF ACETYL-COENZYME A DERIVED ISOPRENOIDS

IPC classification:
C12N 15/52, C12P 5/00, C12P 23/00
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12849489

METHODS OF TREATING CANCER

IPC classification:
A61K 39/00, C07H 21/04, C07K 1/00, C12P 21/08
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12850371

MODIFIED DNA-BINDING PROTEINS AND USES THEREOF

IPC classification:
C07K 14/195, C12N 15/87
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850580

COLLAGEN-LIKE SILK GENES

IPC classification:
A61K 47/42, C07K 14/435, C12N 15/63
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11865925

METHOD OF TREATMENT OR PROPHYLAXIS OF BACTERIAL VAGINOSIS

IPC classification:
A61K 9/00, A61K 31/795, A61K 38/16, A61P 15/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11833192

METHODS AND COMPOSITIONS FOR INDUCING A T-CELL RESPONSE TO PLASMODIUM SPECIES

IPC classification:
A61K 39/015
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP12862964

COMPOSITIONS AND METHODS FOR REGULATING GLUCOSE METABOLISM

IPC classification:
A61K 38/00, C07K 14/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13793997

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION

IPC classification:
C07K 19/00, C12N 5/10, C12N 15/11, C12N 15/63
Applicant:
University of Vienna (Universität Wien)
Applicant:
The Regents of the University of California
Applicant:
Helmholtz Centre for Infection Research - Department Regulation in Infection Biology
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12815166

TARGETING GLI PROTEINS IN HUMAN CANCER BY SMALL MOLECULES

IPC classification:
A61K 31/415, A61K 31/4155, A61P 35/00, C07D 231/06, C07D 409/04
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12786378

ANTI-PROLIFERATIVE COMPOUNDS AND METHODS FOR USING THE SAME

IPC classification:
A01N 43/40, A61K 31/421, A61K 31/4406, C07D 413/04
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11790295

ELECTROPORATION ELECTRODE CONFIGURATION AND METHODS

IPC classification:
A61N 1/32
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12782714

PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

IPC classification:
C12P 5/02
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13746983

IMPROVED ADJUVANT FORMULATIONS COMPRISING TLR4 AGONISTS AND METHODS OF USING THE SAME

IPC classification:
A61K 9/107
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13749899

DIMETHYLARGININE DIMETHYLAMINOHYDROLASE INHIBITORS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/4184, A61K 31/4188
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11766478

FACTOR H BINDING PROTEINS (FHBP) WITH ALTERED PROPERTIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00, C07K 14/00
Applicant:
Novartis Vaccines and Diagnostics Srl
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13765207

NON-HUMAN ANIMAL MODELS OF DEPRESSION AND METHODS OF USE THEREOF

IPC classification:
A01K 67/027, A61N 1/30, A61N 5/06
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13716670

LENTIVIRAL VECTOR PARTICLES HAVING IMPROVED TRANSDUCTION EFFICIENCY FOR CELLS EXPRESSING DC- SIGN

IPC classification:
A61K 39/00, C07K 14/16, C07K 14/18, C12N 15/867
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770214

COMPOSITIONS AND METHODS OF USE FOR TREATING METABOLIC DISORDERS

IPC classification:
A61K 38/00, A61K 38/18, A61K 38/24, C12P 21/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770325

COMPOSITIONS AND METHODS FOR REACTIVATING LATENT IMMUNODEFICIENCY VIRUS

IPC classification:
A61K 31/551
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12858028

COMPOSITIONS AND METHODS FOR INHIBITING IMMUNODEFICIENCY VIRUS TRANSCRIPTION

IPC classification:
A01N 37/10, A61K 31/192, A61K 31/225, A61K 31/46, A61K 31/47, A61K 31/513, A61K 31/551, A61K 31/603, A61K 31/675, A61K 31/7072, A61K 38/16, A61K 45/06, A61P 31/18
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13772583

HERBICIDAL COMPOUND SCREENING

IPC classification:
A01H 1/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Andrew John Thompson, Withers & Rogers LLP
Status:
GRANT OF PATENT INTENDED
EP13751108

COMPOSITIONS AND METHODS FOR TREATING NEUROGENIC DISORDERS OF THE PELVIC FLOOR

IPC classification:
A61P 21/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13760878

METHODS AND COMPOSITIONS FOR TREATING WOUNDS AND REDUCING THE RISK OF INCISIONAL HERNIAS

IPC classification:
A61K 38/00, A61P 17/02
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13779097

COMPOSITIONS AND METHODS FOR DETECTING UNSTABLE ARTERIOSCLEROTIC PLAQUES

IPC classification:
G01N 33/50, G01N 33/573, G01N 33/68
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13777529

METHODS AND SYSTEMS FOR DETECTING AN ANALYTE OR CLASSIFYING A SAMPLE

IPC classification:
C12Q 1/66, G01N 21/76, G01N 33/53
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13788413

METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION OF TRANSGENES

IPC classification:
C12N 5/10, C12N 15/00, C12N 15/87
Applicant:
Dow AgroSciences LLC
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12722048

METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)

IPC classification:
A61P 37/00, C07K 16/28
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13724492

VACCINES FOR HSV-2

IPC classification:
A61K 38/00, C07K 14/005, G01N 33/569
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13770285

SILK POLYPEPTIDES

IPC classification:
A61K 38/17, C07K 14/435, C12N 15/12
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14191235

Cell line, system and method for optical control of secondary messengers

IPC classification:
C12P 21/04, C12P 21/06
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP13799826

COMPOSTIONS AND METHODS FOR CANCER IMMUNOTHERAPY

IPC classification:
A61P 37/04
Applicant:
Johns Hopkins University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13798071

METHOD OF TREATING SCEDOSPORIUM SPP. INFECTION

IPC classification:
A61K 31/36, A61K 31/4184, A61P 31/10
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13820140

ANTIBODY SPECIFIC FOR CD22 AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13836324

COMPOSITIONS AND METHODS FOR TREATING AN ACTIVE MYCOBACTERIUM TUBERCULOSIS INFECTION

IPC classification:
A61K 39/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12739749

METHODS FOR GENERATING INNER EAR CELLS IN VITRO

IPC classification:
A61K 35/30, A61P 27/16, C12N 5/079, G01N 33/50
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12197200

Methods and compositions for determining a graft tolerant phenotype in a subject

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11838856

CONTROL AND CHARACTERIZATION OF MEMORY FUNCTION

IPC classification:
A61K 38/17
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13833614

METHODS OF TREATING CONDITIONS WITH ANTIBODIES THAT BIND COLONY STIMULATING FACTOR 1 RECEPTOR (CSF1R)

IPC classification:
A61K 39/395, A61P 19/02, A61P 29/00, C07K 16/28, C12Q 1/48, G01N 33/564
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13837849

METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE

IPC classification:
A61K 31/198, A61K 31/255, A61P 27/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12706395

METHODS FOR ENHANCING IMMUNOGEN SPECIFIC IMMUNE RESPONSES BY VECTORED VACCINES

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15161439

IMPROVED YIELD AND STRESS TOLERANCE IN TRANSGENIC PLANTS

IPC classification:
A01H 1/00, A01H 5/00, C12N 5/04, C12N 15/82
Applicant:
Monsanto Company
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11764933

ATROPISOMERS OF PI3K-INHIBITING COMPOUNDS

IPC classification:
A61K 31/4985, A61P 29/00, C07D 487/04
Applicant:
Gilead Calistoga LLC
Agent:
Hugh Robin Goodfellow, Carpmaels & Ransford LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13853070

FACULTATIVELY ATTENUATED BACTERIAL SPECIES AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 35/74
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13856783

IMMUNOMODULATORY PEPTIDES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/39, A61K 39/395, A61P 31/12, A61P 37/04, C07K 7/08, C07K 14/555, C07K 14/715, C12N 5/07
Applicant:
The Governors of the University of Alberta
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13859888

METHODS AND COMPOSITIONS FOR REGULATION OF METABOLIC DISORDERS

IPC classification:
C12N 5/10
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862361

METHODS FOR HIGH THROUGHPUT RECEPTOR:LIGAND IDENTIFICATION

IPC classification:
C40B 30/06
Applicant:
Albert Einstein College of Medicine Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15168694

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

IPC classification:
A61K 31/7088, A61K 31/712, A61K 48/00, C07H 21/00, C12N 15/113
Applicant:
University of Western Australia
Agent:
D Young & Co LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863379

COMPOSITIONS COMPRISING CYCLIC PURINE DINUCLEOTIDES HAVING DEFINED STEREOCHEMISTRIES AND METHODS FOR THEIR PREPARATION AND USE

IPC classification:
A61P 37/02, A61P 37/04, C07H 21/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13862780

MODIFIED AXL PEPTIDES AND THEIR USE IN INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

IPC classification:
A61K 31/00, C07K 14/47, C07K 16/18, C07K 16/28, C07K 16/40
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13869448

SIGNAL PEPTIDE FUSION PARTNERS FACILITATING LISTERIAL EXPRESSION OF ANTIGENIC SEQUENCES AND METHODS OF PREPARATION AND USE THEREOF

IPC classification:
A61K 39/00, C07K 14/195, C12N 15/74
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14740804

GROWTH FACTOR SEQUESTERING AND PRESENTING HYDROGELS

IPC classification:
C12N 5/02, C12N 11/04
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14743956

TARGETING GLI PROTEINS IN HUMAN CANCER BY SMALL MOLECULES

IPC classification:
A61K 31/415
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14743049

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE

IPC classification:
A61K 38/43, A61K 38/46, A61K 38/48
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14704239

PHARMACEUTICAL FORMULATION COMPRISING AN INSOLUBLE CORTICOSTEROID AND A SOLUBLE CORTICOSTEROID

IPC classification:
A61K 31/573, A61K 47/36
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
Cooley (UK) LLP
Status:
GRANT OF PATENT INTENDED
EP13874703

ENDOPHYTIC MICROBIAL SYMBIONTS IN PLANT PRENATAL CARE

IPC classification:
A01H 5/10, A01H 17/00, A01N 63/02, A01N 63/04, A01P 3/00, A01P 21/00, B09C 1/10, C12N 1/14, C12N 1/20, C12N 15/00
Applicant:
University of Saskatchewan Industry Liaison Office
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14751227

CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

IPC classification:
A61K 48/00, C07K 14/705, C07K 16/28, C12N 5/0783
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14751523

COMPOSITIONS AND METHODS OF USE THEREOF FOR IDENTIFYING ANTI-VIRAL AGENTS

IPC classification:
C12Q 1/70
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14756984

GENERATION OF THYMIC EPITHELIAL PROGENITOR CELLS IN VITRO

IPC classification:
C12N 5/02
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14753924

METHODS AND COMPOSITIONS FOR ENHANCING NUCLEASE-MEDIATED GENE DISRUPTION

IPC classification:
C12N 9/16
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15177471

METHOD OF TARGETED GENE DELIVERY USING VIRAL VECTORS

IPC classification:
A61K 39/00, C07K 16/28, C12N 15/86
Applicant:
California Institute of Technology
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779898

METHODS AND COMPOSITIONS FOR MODIFICATION OF HLA

IPC classification:
C12N 5/00, C12N 5/02, C12N 5/0783
Applicant:
The Board of Regents of the University of Texas System
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14770952

COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION

IPC classification:
A61P 31/18, C12N 15/113
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773609

FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF

IPC classification:
C07K 16/28
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768321

PURIFICATION OF TRIPLE HELICAL PROTEINS

IPC classification:
C07K 1/14, C07K 1/30
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Paul Gilmour Chapman, Marks & Clerk LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14779659

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY

IPC classification:
A61P 31/12
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14731420

GLA MONOTHERAPY FOR USE IN CANCER TREATMENT

IPC classification:
A61K 31/7028, A61P 35/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14784959

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/00, A61P 31/04, C07K 14/54
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14785742

G PROTEIN COUPLED RECEPTOR LIBRARIES

IPC classification:
C07K 14/705, C12N 15/81, C12Q 1/02, C40B 40/02, G01N 33/22, G01N 33/566
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP14794007

ENRICHMENT OF DNA SEQUENCING LIBRARIES FROM SAMPLES CONTAINING SMALL AMOUNTS OF TARGET DNA

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14778308

METHODS OF TREATING DISEASES CHARACTERIZED BY EXCESSIVE WNT SIGNALLING

IPC classification:
A61K 31/00, A61K 31/519, A61K 31/7088, A61K 39/395, A61P 35/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14884476

E1E2 HCV VACCINES AND METHODS OF USE

IPC classification:
A61K 39/29, A61P 31/14
Applicant:
The Governors of the University of Alberta
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12705186

GEL-ENCAPSULATED MICROCOLONY SCREENING

IPC classification:
C12P 5/00, C12Q 1/02, G01N 33/50
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15191395

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 38/16, A61K 47/48, C07K 14/195, C07K 14/21, C07K 19/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15191391

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 38/16, A61K 47/48, C07K 14/195, C07K 14/21, C07K 19/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15191388

MUTATED PSEUDOMONAS EXOTOXINS WITH REDUCED ANTIGENICITY

IPC classification:
A61K 38/16, A61K 47/48, C07K 14/195, C07K 14/21, C07K 19/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14806809

COMPOSITIONS AND METHODS FOR REDUCING OR PREVENTING METASTASIS

IPC classification:
A61K 39/39
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14810750

TRANSAMINASE BIOCATALYSTS

IPC classification:
C07K 14/21, C12N 9/10, C12N 15/54, C12P 7/44, C12P 13/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11811474

WHOLE BLOOD ASSAY FOR MEASURING AMPK ACTIVATION

IPC classification:
C12N 9/12, G01N 33/50
Applicant:
Rigel Pharmaceuticals Inc
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14748326

SEED-ORIGIN ENDOPHYTE POPULATIONS, COMPOSITIONS, AND METHODS OF USE

IPC classification:
A01C 1/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14803589

ADENO-ASSOCIATED VIRUS VARIANTS AND METHODS OF USE THEREOF

IPC classification:
A61K 35/76, A61K 48/00, C12N 7/00
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15196123

PRODUCTION OF ISOPRENOIDS AND ISOPRENOID PRECURSORS

IPC classification:
C12N 1/00, C12N 9/12, C12N 9/88
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11838859

UPCONVERSION OF LIGHT FOR USE IN OPTOGENETIC METHODS

IPC classification:
A61K 41/00, A61K 48/00, A61M 37/00, A61N 5/06, B82Y 5/00
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14752705

AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14831454

NON-NATURALLY OCCURRING FACTOR H BINDING PROTEINS (FHBP) AND METHODS OF USE THEREOF

IPC classification:
A61K 39/095
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15190341

ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF

IPC classification:
A61K 31/7088, A61K 31/712, A61K 48/00, C07H 21/00, C12N 15/113
Applicant:
University of Western Australia
Agent:
D Young & Co LLP
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13748255

METHODS FOR STABILIZING PRODUCTION OF ACETYL-COENZYME A DERIVED COMPOUNDS

IPC classification:
C12N 1/16, C12N 15/81, C12P 5/00
Applicant:
TOTAL MARKETING SERVICES
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15200471

PRODUCTION OF ISOPRENOIDS

IPC classification:
C12N 15/52, C12P 5/00, C12P 7/00, C12P 7/02, C12P 7/04
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13160448

Cell line, system and method for optical control of secondary messengers

IPC classification:
C12P 21/04, C12P 21/06
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14836465

COMPOSITIONS AND METHODS FOR CONTROLLING PAIN

IPC classification:
C12N 15/864
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14840710

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 38/20
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14843092

VACCINE COMPOSITIONS FOR DRUG ADDICTION

IPC classification:
A61K 31/7028, A61K 39/00, C07K 17/02
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14777213

AGRICULTURAL ENDOPHYTE-PLANT COMPOSITIONS, AND METHODS OF USE

IPC classification:
A01C 1/06
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14842530

MODIFIED BACTERIAL COLLAGEN-LIKE PROTEINS

IPC classification:
A61K 8/65, A61K 38/16, C07K 14/78, C12N 15/31, C12P 21/02
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11751114

ANTIBODY SPECIFIC FOR APOLIPOPROTEIN AND METHODS OF USE THEREOF

IPC classification:
C07K 16/18
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11730818

FZD8 EXTRACELLULAR DOMAINS AND FZD8 EXTRACELLULAR DOMAIN FUSION MOLECULES FOR USE IN TREATING OBESITY AND OBESITY-RELATED DISORDERS

IPC classification:
A61K 38/17, A61K 47/00, A61K 47/30, A61P 3/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11746707

GRAFT COPOLYMERS OF POLYFARNESENES WITH CONDENSATION POLYMERS

IPC classification:
C08C 19/28, C08F 279/02, C08G 81/02
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755188

NUCLEIC ACIDS, COMPOSITIONS AND METHODS FOR THE EXCISION OF TARGET NUCLEIC ACIDS

IPC classification:
C12N 15/81
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14853797

DELIVERY METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED GENOME ENGINEERING IN HEMATOPOIETIC STEM CELLS

IPC classification:
A01N 63/00, C07H 21/04, C12N 5/00, C12N 15/00, C12N 15/87, C12P 21/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11822439

METHOD AND COMPOSITION FOR CRYSTALLIZING A FAMILY C GPCR

IPC classification:
C07K 14/705, C07K 19/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14860187

FUNGAL ENDOPHYTES FOR IMPROVED CROP YIELDS AND PROTECTION FROM PESTS

IPC classification:
A01H 5/00, A01N 63/00, A01N 65/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14860137

METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13154260

Methods of purifying a nucleic acid and formulation and kit for use in performing such methods

IPC classification:
C12N 15/10, C12Q 1/68
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11824052

DIETARY SUPPLEMENT AND METHODS OF USE THEREOF

IPC classification:
A23G 3/36, A23L 1/303, A23L 1/304, A61K 33/26, A61K 38/16
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14866453

METHOD OF DETECTING PLASMODIUM INFECTION

IPC classification:
C12Q 1/04, G01N 33/48, G01N 33/497
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP11838862

OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS

IPC classification:
A01K 67/027, G01N 33/50
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP11787200

METHODS AND COMPOSITIONS USING LISTERIA FOR ADJUVANT TREATMENT OF CANCER

IPC classification:
A61K 35/74, C12N 15/75
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12742056

METHODS OF DEVELOPING TERPENE SYNTHASE VARIANTS

IPC classification:
C12N 9/88, C12Q 1/527
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14869305

METHODS AND COMPOSITIONS FOR TREATING HEMOPHILIA

IPC classification:
C07K 14/00
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14869259

METHODS AND COMPOSITIONS FOR MODIFYING A SINGLE STRANDED TARGET NUCLEIC ACID

IPC classification:
C12N 9/96
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16167704

ENDORIBONUCLEASE COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
C12N 9/22, C12N 15/55, C12Q 1/34, C12Q 1/68, G01N 33/573
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14876108

CAS9 CRYSTALS AND METHODS OF USE THEREOF

IPC classification:
C07K 14/315, C12N 9/00, C12P 19/34
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15735215

IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00, A61K 39/39, A61P 37/04
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15703170

COMPOSITIONS FOR USE IN THE TREATMENT OF ALLERGIC CONDITIONS

IPC classification:
A61K 31/7024, A61P 37/08
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748477

PARTITIONING OF DNA SEQUENCING LIBRARIES INTO HOST AND MICROBIAL COMPONENTS

IPC classification:
C12Q 1/00, C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Agent:
De Clercq & Partners cvba
Status:
EXAMINATION REQUESTED
EP15709383

IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15748774

METHOD OF DETECTING CANCER

IPC classification:
G01N 33/574
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15752803

METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION

IPC classification:
A61K 48/00, C12N 5/10, C12N 15/64
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15777221

METHODS AND COMPOSITIONS FOR USING ARGONAUTE TO MODIFY A SINGLE STRANDED TARGET NUCLEIC ACID

IPC classification:
C07K 14/195, C12N 15/63, C12P 19/34
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15723609

SOLVENT COMPOSITIONS BASED ON DIHYDROFARNESENE

IPC classification:
A61K 8/31, A61Q 1/04, A61Q 5/06, A61Q 19/00, C11D 3/18, C11D 7/50
Applicant:
Amyris, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15786844

INHIBITORS OF JMJD2C AS ANTICANCER AGENTS

IPC classification:
A61K 31/4709, C07D 215/24
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP15789214

METHODS AND COMPOSITIONS FOR TREATING HUNTINGTON'S DISEASE

IPC classification:
A61K 38/00, A61K 38/16, A61K 38/54, A61K 48/00, C07H 21/04
Applicant:
Sangamo BioSciences, Inc.
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803224

COMPOSITIONS AND METHODS FOR TARGETING A PATHWAY

IPC classification:
C07K 1/00, C07K 14/00, C07K 16/00, C07K 17/00, C12P 21/08
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15745647

PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR

IPC classification:
A61K 39/00
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16189132

SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS

IPC classification:
A61K 31/713, C07K 14/47
Applicant:
Stanford University - Office of The General Counsel
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
APPLICATION PUBLISHED
EP15838726

METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION

IPC classification:
A61K 48/00, C07H 21/02, C12P 19/34
Applicant:
The Regents of the University of California
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made
EP16197498

DEVICES FOR OPTICAL STIMULATION OF TARGET CELLS USING AN OPTICAL TRANSMISSION ELEMENT

IPC classification:
A61N 5/06
Applicant:
Stanford University - Office of The General Counsel
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
The application has been published
EP15747902

METHODS FOR PREPARING PLATELET PRODUCTS

IPC classification:
A61K 35/19, C12N 5/078
Agent:
Adrian Hugh Brasnett, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature